Literature DB >> 11399322

Heterogeneity of O-glycosylation in the hinge region of human IgA1.

J Novak1, M Tomana, M Kilian, L Coward, R Kulhavy, S Barnes, J Mestecky.   

Abstract

Matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry was applied to studies of the molecular heterogeneity of desialylated human IgA1 hinge region glycopeptides released with two IgA1 proteases. Typically, the hinge region of an alpha1 chain contains three to five O-linked glycan chains. Variants of the hinge region peptides released from IgA1(Kni) myeloma protein carrying 0, 1, 2, or 3 GalNAc residues were observed in the mass spectra as well as the nonglycosylated peptide. Variable numbers of Gal residues indicated additional heterogeneity in O-glycosylation of IgA1. In the hinge region preparation from normal human serum IgA1, glycopeptides carrying 2, 3, 4, or 5 GalNAc residues with variable numbers of Gal residues were detected. In conclusion, our new approach using the site-specific cleavage with two IgA1 proteases allowed precise and sensitive MALDI-TOF mass spectrometric analysis of O-glycosylation heterogeneity in IgA1 hinge region.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11399322     DOI: 10.1016/s0161-5890(01)00019-0

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  36 in total

Review 1.  Progress in molecular and genetic studies of IgA nephropathy.

Authors:  J Novak; B A Julian; M Tomana; J Mesteck
Journal:  J Clin Immunol       Date:  2001-09       Impact factor: 8.317

2.  Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study.

Authors:  Michelle M Gomes; Hitoshi Suzuki; Monica T Brooks; Milan Tomana; Zina Moldoveanu; Jiri Mestecky; Bruce A Julian; Jan Novak; Andrew B Herr
Journal:  Biochemistry       Date:  2010-07-13       Impact factor: 3.162

3.  Naturally occurring structural isomers in serum IgA1 o-glycosylation.

Authors:  Kazuo Takahashi; Archer D Smith; Knud Poulsen; Mogens Kilian; Bruce A Julian; Jiri Mestecky; Jan Novak; Matthew B Renfrow
Journal:  J Proteome Res       Date:  2011-12-29       Impact factor: 4.466

4.  The combined role of galactose-deficient IgA1 and streptococcal IgA-binding M Protein in inducing IL-6 and C3 secretion from human mesangial cells: implications for IgA nephropathy.

Authors:  Roland Schmitt; Anne-Lie Ståhl; Anders I Olin; Ann-Charlotte Kristoffersson; Johan Rebetz; Jan Novak; Gunnar Lindahl; Diana Karpman
Journal:  J Immunol       Date:  2014-05-21       Impact factor: 5.422

5.  Reactivities of N-acetylgalactosamine-specific lectins with human IgA1 proteins.

Authors:  Jennifer S Moore; Rose Kulhavy; Milan Tomana; Zina Moldoveanu; Hitoshi Suzuki; Rhubell Brown; Stacy Hall; Mogens Kilian; Knud Poulsen; Jiri Mestecky; Bruce A Julian; Jan Novak
Journal:  Mol Immunol       Date:  2007-02-02       Impact factor: 4.407

6.  Characterization of a plant-produced recombinant human secretory IgA with broad neutralizing activity against HIV.

Authors:  Matthew Paul; Rajko Reljic; Katja Klein; Pascal M W Drake; Craig van Dolleweerd; Martin Pabst; Markus Windwarder; Elsa Arcalis; Eva Stoger; Friedrich Altmann; Catherine Cosgrove; Angela Bartolf; Susan Baden; Julian K-C Ma
Journal:  MAbs       Date:  2014       Impact factor: 5.857

7.  FcαRI binding at the IgA1 CH2-CH3 interface induces long-range conformational changes that are transmitted to the hinge region.

Authors:  Monica T Posgai; Sam Tonddast-Navaei; Manori Jayasinghe; George M Ibrahim; George Stan; Andrew B Herr
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-04       Impact factor: 11.205

8.  Update on immunoglobulin A nephropathy, Part I: Pathophysiology.

Authors:  Maurizio Salvadori; Giuseppina Rosso
Journal:  World J Nephrol       Date:  2015-09-06

Review 9.  Pathogenesis of Henoch-Schönlein purpura nephritis.

Authors:  Keith K Lau; Hitoshi Suzuki; Jan Novak; Robert J Wyatt
Journal:  Pediatr Nephrol       Date:  2009-06-13       Impact factor: 3.714

Review 10.  Specific antibody activity, glycan heterogeneity and polyreactivity contribute to the protective activity of S-IgA at mucosal surfaces.

Authors:  Jiri Mestecky; Michael W Russell
Journal:  Immunol Lett       Date:  2009-04-05       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.